Proteomic analysis identifies nuclear protein effectors in PKC-δ signaling under high glucose-induced apoptosis in human umbilical vein endothelial cells

Molecular Medicine Reports

Volumn 4, Issue 5, 2011, Pages 865-872

  Sun, Fang ^a   Zhou, Bo ^a   Lin, Xuebo ^a   Duan, Lian ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Diabetic complication; Nuclear translocation; Protein kinase C ; Proteomics

Indexed keywords

GLUCOSE; NUCLEAR PROTEIN; PROTEIN KINASE C DELTA; ROTTLERIN;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL CYCLE; CELL NUCLEUS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GLUCOSE; HUMANS; NUCLEAR PROTEINS; PEPTIDE MAPPING; PROTEIN KINASE C-DELTA; PROTEIN TRANSPORT; PROTEOMICS; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; UMBILICAL VEINS; UP-REGULATION;

ADENOVIRIDAE; ANIMALIA;

EID: 79960421314     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.531     Document Type: Article

References (28)

1. Bakker W, Eringa EC, Sipkema P and van Hinsbergh VW: Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res 335: 165-189, 2009.
2. Orasanu G and Plutzky J: The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 53: S35-S42, 2009.
3. Srivastava S, Ramana KV, Tammali R, Srivastava SK and Bhatnagar A: Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells. Diabetes 55: 901-910, 2006. (Pubitemid 44100162)
4. Chan KC, Wang CJ, Ho HH, Chen HM and Huang CN: Simvastatin inhibits cell cycle progression in glucose-stimulated proliferation of aortic vascular smooth muscle cells by up-regulating cyclin dependent kinase inhibitors and p53. Pharmacol Res 58: 247-256, 2008.
5. Li Y, Wu H, Khardori R, Song YH, Lu YW and Geng YJ: Insulin-like growth factor-1 receptor activation prevents high glucose-induced mitochondrial dysfunction, cytochrome-c release and apoptosis. Biochem Biophys Res Commun 384: 259-264, 2009.
6. Simone S, Gorin Y, Velagapudi C, Abboud HE and Habib SL: Mechanism of oxidative DNA damage in diabetes: tuberin inactivation and downregulation of DNA repair enzyme 8-oxo-7,8-dihydro-2′-deoxyguanosine-DNA glycosylase. Diabetes 57: 2626-2636, 2008.
7. Meier M, Menne J and Haller H: Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice. Diabetologia 52: 765-775, 2009.
8. Kanwar M and Kowluru RA: Role of glyceraldehyde 3-phosphate dehydrogenase in the development and progression of diabetic retinopathy. Diabetes 58: 227-234, 2009.
9. Ma RC, Tam CH, Wang Y, et al: Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes. JAMA 304: 881-889, 2010.
10. Gaudreault N, Perrin RM, Guo M, Clanton CP, Wu MH and Yuan SY: Counter regulatory effects of PKCbetaII and PKCdelta on coronary endothelial permeability. Arterioscler Thromb Vasc Biol 28: 1527-1533, 2008.
11. Park JY, Takahara N, Gabriele A, et al: Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes 49: 1239-1248, 2000. (Pubitemid 30439101)
12. Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, et al: Activation of PKCd and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med 15: 1298-1307, 2009.
13. Khamaisi M, Dahan R, Hamed S, Abassi Z, Heyman SN and Raz I: Role of protein kinase C in the expression of endothelin converting enzyme-1. Endocrinology 150: 1440-1449, 2009.
14. Hayashida T and Schnaper HW: High ambient glucose enhances sensitivity to TGF-beta1 via extracellular signal-regulated kinase and protein kinase Cdelta activities in human mesangial cells. J Am Soc Nephrol 15: 2032-2041, 2004. (Pubitemid 39031342)
15. Horovitz-Fried M, Brutman-Barazani T, Kesten D and Sampson SR: Insulin increases nuclear protein kinase Cdelta in L6 skeletal muscle cells. Endocrinology 149: 1718-1727, 2008. (Pubitemid 351468338)
16. Sud N, Wedgwood S and Black SM: Protein kinase Cdelta regulates endothelial nitric oxide synthase expression via Akt activation and nitric oxide generation. Am J Physiol Lung Cell Mol Physiol 294: L582-L591, 2008. (Pubitemid 351468858)
17. Hennige AM, Ranta F, Heinzelmann I, et al: Overexpression of kinase-negative protein kinase Cdelta in pancreatic beta-cells protects mice from diet-induced glucose intolerance and beta-cell dysfunction. Diabetes 59: 119-127, 2010.
18. Turck N, Richert S, Gendry P, et al: Proteomic analysis of nuclear proteins from proliferative and differentiated human colonic intestinal epithelial cells. Proteomics 4: 93-105, 2004. (Pubitemid 38140878)
19. Lim JH, Park JW, Kim SH, Choi YH, Choi KS and Kwon TK: Rottlerin induces pro-apoptotic endoplasmic reticulum stress through the protein kinase C-delta-independent pathway in human colon cancer cells. Apoptosis 13: 1378-1385, 2008.
20. Soltoff SP: Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. Trends Pharmacol Sci 28: 453-458, 2007.
21. Boini KM, Hennige AM, Huang DY, et al: Serum- and glucocorticoid- inducible kinase 1 mediates salt sensitivity of glucose tolerance. Diabetes 55: 2059-2066, 2006. (Pubitemid 44509980)
22. Hills CE, Squires PE and Bland R: Serum and glucocorticoid regulated kinase and disturbed renal sodium transport in diabetes. J Endocrinol 199: 343-349, 2008.
23. Kumar JM, Brooks DP, Olson BA and Laping NJ: Sgk, a putative serine/threonine kinase, is differentially expressed in the kidney of diabetic mice and humans. J Am Soc Nephrol 10: 2488-2494, 1999.
24. Brunet A, Park J, Tran H, Hu LS, Hemmings BA and Greenberg ME: Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21: 952-965, 2001. (Pubitemid 32104742)
25. Wolf G, Wenzel U, Ziyadeh FN and Stahl RA: Angiotensin converting-enzyme inhibitor treatment reduces glomerular p16INK4 and p27Kip1 expression in diabetic BBdp rats. Diabetologia 42: 1425-1432, 1999. (Pubitemid 30012314)
26. Sanghera DK, Ortega L, Han S, et al: Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet 9: 59, 2008.
27. Liu W, Sun M, Jiang J, Shen X, Sun Q, Shen H and Gu J: Cyclin D3 interacts with human activating transcription factor 5 and potentiates its transcription activity. Biochem Biophys Res Commun 321: 954-960, 2004. (Pubitemid 39044401)
28. Choi SL, Choi YS, Kim YK, et al: Proteomic analysis and the antimetastatic effect of N-(4-methyl)phenyl-O-(4-methoxy) phenyl- thionocarbamate-induced apoptosis in human melanoma SK-MEL-28 cells. Arch Pharm Res 29: 224-234, 2006.